As CF treatment duration extends, registry-based analyses will need to track pathogen-specific trends and long-term disease ...
Johnson & Johnson's Tremfya is the first IL-23 inhibitor to gain FDA approval in a paediatric population for plaque psoriasis ...
China’s National Medical Products Administration (NMPA) has granted approval for four-weekly intravenous (IV) maintenance ...
Oral liquid drugs play a vital role for patients who have difficulty swallowing tablets and for those requiring personalised ...
How to build flexibility into your CGT manufacturing process while maintaining regulatory compliance
MasterControl research shows 40% of advanced therapy executives aren't confident they can meet CGT demand over the next three ...
More than two-thirds – 67% - of first responders organisations have deployed new cybersecurity protections in the last 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback